Glenmede Trust’s Amrize Ltd AMRZ Stock Holding History

Glenmede Trust’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,815	Closed	-$270K	–	1589
2026 Q1	$270K	Buy	+4,815	New	+$276K	﹤0.01%	1201

Other funds holding AMRZ

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's AMRZ Position: Q2 2026 in Review

Glenmede Trust sold out of Amrize Ltd (AMRZ) in Q2 2026, closing a stake of 4,815 shares — an estimated $270K sold.

Glenmede Trust first reported a position in AMRZ in Q1 2026 and held it in 1 quarter. The position peaked at $270K in Q1 2026. 463 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

Glenmede Trust reported no remaining Amrize Ltd position as of Q2 2026 after selling out during the quarter.
Glenmede Trust sold 4,815 Amrize Ltd shares in Q2 2026, an estimated $270K.
Glenmede Trust first reported a position in Amrize Ltd in Q1 2026 and held it in 1 quarter.
Glenmede Trust's Amrize Ltd position peaked at $270K in Q1 2026.
463 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.